Established in 2018, Cure8 Ventures is an early-stage investment firm headquartered in Saint Louis, Missouri. It specializes in investing within the food, healthcare, and wellness sectors.
Founded in 2015, Exciva is a German biopharmaceutical company headquartered in Heidelberg. It focuses on developing targeted drug rescue programs to create symptomatic treatments and disease-modifying therapies for various indications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.